Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2014 Filed Jun 4, 2014 21:51 UTC |
SEVERINO MICHAELEVP, R&D and CSO
|
GrantCommon stock, $0.01 par value | 141,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-009765 · edgar.xml · nonDerivative · entry 1 SEVERINO MICHAEL · CIK 0001609447 · EVP, R&D and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,625 F1 · shares: This stock represents performance vested restricted stock under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have a stock withheld for tax purposes. Read SEC document |
| May 09, 2014 Filed May 13, 2014 21:19 UTC |
Alpern Robert JDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008312 · edgar.xml · nonDerivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,858 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 21:20 UTC |
AUSTIN ROXANNE SDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008314 · edgar.xml · nonDerivative · entry 1 AUSTIN ROXANNE S · CIK 0001061632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,365 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 17:21 UTC |
LIDDY EDWARD MDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008318 · edgar.xml · nonDerivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,420 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 21:20 UTC |
BURNSIDE WILLIAM H.L.Director
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008316 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,299 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 21:23 UTC |
RAPP EDWARD JDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008323 · edgar.xml · nonDerivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,799 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 17:26 UTC |
ROBERTS ROY SDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008324 · edgar.xml · nonDerivative · entry 1 ROBERTS ROY S · CIK 0001200813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,299 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 17:28 UTC |
TILTON GLENN FDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008325 · edgar.xml · nonDerivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,505 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 21:29 UTC |
WADDELL FREDERICK HDirector
|
GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008326 · edgar.xml · nonDerivative · entry 1 WADDELL FREDERICK H · CIK 0001223690 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,299 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2014 Filed Apr 2, 2014 21:05 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 153 | $51.40 Strike: $0.00 | $7,864.20 |
DisclosureSEC source: 0001179110-14-006276 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 877 Underlying: Common Stock · 153 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2014 Filed Apr 2, 2014 21:06 UTC |
RAPP EDWARD JDirector
|
GrantStock Equivalent Units · Derivative | 642 | $51.40 Strike: $0.00 | $32,998.80 |
DisclosureSEC source: 0001179110-14-006279 · edgar.xml · derivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,677 Underlying: Common Stock · 642 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2014 Filed Apr 2, 2014 17:07 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 671 | $51.40 Strike: $0.00 | $34,489.40 |
DisclosureSEC source: 0001179110-14-006280 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,844 Underlying: Common Stock · 671 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2014 Filed Jul 2, 2014 17:16 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 671 | $51.40 Strike: $0.00 | $34,489.40 |
DisclosureSEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 5 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,990 Underlying: Common stock · 671 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature. Read SEC document |
| March 18, 2014 Filed Nov 26, 2014 17:00 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
GiftCommon stock, $0.01 par value | 9,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-017219 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,328 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 500 | $51.21 | $25,607.00 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,403 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 2,230 | $51.20 | $114,176.00 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,903 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 1,800 | $51.20 | $92,152.80 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,133 Read SEC document |
| March 04, 2014 Filed Mar 4, 2014 17:13 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
SaleCommon stock, $0.01 par value | 269 | $51.19 | $13,770.11 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,933 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:10 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
SaleCommon stock, $0.01 par value | 600 | $50.09 | $30,056.40 |
DisclosureSEC source: 0001179110-14-004322 · edgar.xml · nonDerivative · entry 5 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,138 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:10 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
SaleCommon stock, $0.01 par value | 400 | $50.09 | $20,036.40 |
DisclosureSEC source: 0001179110-14-004322 · edgar.xml · nonDerivative · entry 4 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,738 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:10 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
SaleCommon stock, $0.01 par value | 282 | $50.09 | $14,125.38 |
DisclosureSEC source: 0001179110-14-004322 · edgar.xml · nonDerivative · entry 3 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,138 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:10 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
SaleCommon stock, $0.01 par value | 1,600 | $50.09 | $80,137.60 |
DisclosureSEC source: 0001179110-14-004322 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,420 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:12 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
SaleCommon stock, $0.01 par value | 100 | $51.20 | $5,119.50 |
DisclosureSEC source: 0001179110-14-004329 · edgar.xml · nonDerivative · entry 4 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,068 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:12 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
SaleCommon stock, $0.01 par value | 1,400 | $50.19 | $70,271.60 |
DisclosureSEC source: 0001179110-14-004329 · edgar.xml · nonDerivative · entry 3 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,168 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:12 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
SaleCommon stock, $0.01 par value | 2,448 | $50.19 | $122,867.57 |
DisclosureSEC source: 0001179110-14-004329 · edgar.xml · nonDerivative · entry 2 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,568 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 100 | $50.26 | $5,026.40 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 8 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,828 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 200 | $50.26 | $10,052.60 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 7 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,928 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 100 | $50.26 | $5,026.10 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 6 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,128 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 100 | $50.25 | $5,025.30 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,228 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 581 | $50.25 | $29,195.25 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 4 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,328 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 1,200 | $50.25 | $60,295.20 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 3 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,909 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 162 | $50.24 | $8,138.88 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,109 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:18 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
SaleCommon stock, $0.01 par value | 2,500 | $50.03 | $125,085.00 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,585 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:18 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
SaleCommon stock, $0.01 par value | 100 | $50.03 | $5,003.10 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,085 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:18 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
SaleCommon stock, $0.01 par value | 1,543 | $50.03 | $77,196.29 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,185 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:10 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
Tax withholdingCommon stock, $0.01 par value | 15,319 | $50.91 | $779,890.29 |
DisclosureSEC source: 0001179110-14-004322 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,020 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:12 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Tax withholdingCommon stock, $0.01 par value | 9,873 | $51.91 | $512,507.43 |
DisclosureSEC source: 0001179110-14-004329 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,016 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 17:13 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
Tax withholdingCommon stock, $0.01 par value | 46,811 | $50.91 | $2,383,148.01 |
DisclosureSEC source: 0001179110-14-004333 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,202 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:13 UTC |
HURWICH THOMAS A.VP, Controller
|
Tax withholdingCommon stock, $0.01 par value | 3,360 | $50.91 | $171,057.60 |
DisclosureSEC source: 0001179110-14-004335 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,448 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:14 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
Tax withholdingCommon stock, $0.01 par value | 6,669 | $50.91 | $339,518.79 |
DisclosureSEC source: 0001179110-14-004341 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,384 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:17 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Tax withholdingCommon stock, $0.01 par value | 6,336 | $51.91 | $328,901.76 |
DisclosureSEC source: 0001179110-14-004347 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,271 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:18 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
Tax withholdingCommon stock, $0.01 par value | 21,940 | $50.91 | $1,116,965.40 |
DisclosureSEC source: 0001179110-14-004349 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,728 Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:06 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
GrantOption (right to buy) · Derivative | 81,500 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003466 · edgar.xml · derivative · entry 3 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,500 Underlying: Common stock · 81,500 shares Expires 2024-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 27,167 on 02/20/2015, 27,166 on 02/20/2016, and 27,167 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:06 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
GrantCommon stock, $0.01 par value | 47,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003466 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,339 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:06 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
GrantOption (right to buy) · Derivative | 92,740 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003467 · edgar.xml · derivative · entry 3 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,740 Underlying: Common stock · 92,740 shares Expires 2024-02-19 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 30,914 on 02/20/2015, 30,913 on 02/20/2016, and 30,913 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:06 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
GrantCommon stock, $0.01 par value | 53,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003467 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,889 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 17:07 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
GrantOption (right to buy) · Derivative | 281,030 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003470 · edgar.xml · derivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,030 Underlying: Common stock · 281,030 shares Expires 2024-02-19 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 93,677 on 02/20/2015, 93,676 on 02/20/2016, and 93,677 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 17:07 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
GrantCommon stock, $0.01 par value | 162,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003470 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,013 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:19 UTC |
HURWICH THOMAS A.VP, Controller
|
GrantOption (right to buy) · Derivative | 21,070 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003477 · edgar.xml · derivative · entry 4 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,070 Underlying: Common stock · 21,070 shares Expires 2024-02-19 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 7,024 on 02/20/2015, 7,023 on 02/20/2016, and 7,023 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:19 UTC |
HURWICH THOMAS A.VP, Controller
|
GrantCommon stock, $0.01 par value | 12,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003477 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,808 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.